Centene Corp (CNC · NYSE)
CNC · MARKET VIEW
Market view · as of Oct 12, 2026
Revenue (TTM)
$180.30B
+4.6% YoY
Gross margin
11.4%
EPS (latest q)
$2.51
vs $0.89 est · beat
52-wk position
89.2%
-5.8% vs 52w high · -1.6% 1mo
Price (last ~year)
Centene returned to profitability in 2026 after two straight loss-making quarters in late 2025, posting June-quarter net income of $1.09B on revenue of $44.38B and beating consensus EPS estimates in all four of its last reports ($2.51 vs. $0.89 most recently). The stock trades at $65.36, up 1.3% on the day and 22.3% above its 200-day SMA, though 5.8% below its 52-week high of $69.63. Leverage stands at 3.5x debt/EBITDA with $24.15B in cash against $16.11B in total debt, and trailing-twelve-month revenue of $180.30B grew 4.6% year over year. Valuation metrics remain low—P/S of 0.179, EV/EBITDA of 3.91, and PEG of 0.748—against an analyst target of $71.78.
Valuation
- Market cap
- $32.29B
- PEG
- 0.748
- P/B
- 1.359
- P/S
- 0.179
- EV/EBITDA
- 3.91
- Beta
- 1.13
- Analyst target
- $71.78
Quality & returns
- Gross margin
- 11.4%
- Operating margin
- 3.8%
- Profit margin
- -2.8%
- ROE
- -20.4%
- ROA
- 2.5%
Price movement
- Last
- $65.36
- 1-month
- -1.6%
- 3-month
- +2.3%
- RSI (14)
- 52
- vs SMA200
- +22.3%
- 52-wk position
- 89.2% -5.8% vs high
Quarterly trajectory
Revenue by quarter (oldest → newest)
| Quarter | Revenue | Op income | Net income | EBITDA |
|---|---|---|---|---|
| 2026-06-30 | $44.38B | $1.38B | $1.09B | $1.94B |
| 2026-03-31 | $49.94B | $1.86B | $1.54B | $2.56B |
| 2025-12-31 | $49.73B | $-1.74B | $-1.10B | $-1.05B |
| 2025-09-30 | $49.69B | $-6.95B | $-6.63B | $-6.19B |
Recent news
- Neutral Form 4 Centene Corp For: 11 October By Investing.com · 2026-10-11
- Neutral Can OceanaGold (TSX:OGC) Sustain Its MidCap Gold Producer Momentum Higher? · 2026-10-10
- Neutral Humana Stock Rockets As CMS Star Ratings Spark Bullish Repricing · 2026-10-09
- Neutral HCA Healthcare stock sits at EUR 402.10, market cap USD 97.5 billion · 2026-10-09
- Neutral Humana soars, Alignment plummets in 2027 Medicare Advantage star ratings · 2026-10-09
- Neutral Centene Corp. stock underperforms Friday when compared to competitors despite daily gains · 2026-10-09
Sources this view read
- fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
- filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
- earnings Reported earnings history (Alpha Vantage EARNINGS)
- prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)